Overview

Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of the PETAL trial is to determine whether patients with aggressive non-Hodgkin's lymphomas with a persistently positive PET scan after two cycles of chemotherapy benefit from a change of the treatment protocol.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Essen
Collaborator:
Deutsche Krebshilfe e.V., Bonn (Germany)
Treatments:
Cyclophosphamide
Doxorubicin
Prednisone
Rituximab
Vincristine